MedPath
HSA Approval

CEFTRIAXONE-AFT POWDER FOR INJECTION 2G/VIAL

SIN15208P

CEFTRIAXONE-AFT POWDER FOR INJECTION 2G/VIAL

CEFTRIAXONE-AFT POWDER FOR INJECTION 2G/VIAL

April 11, 2017

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

J01DD04

ceftriaxone

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

Qilu Pharmaceutical Co Ltd

Active Ingredients

CEFTRIAXONE SODIUM 2.159g eqv to CEFTRIAXONE BASE

2g/vial

Ceftriaxone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.